• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高稳定性纳米晶体递送白果内酯 B 以预防帕金森病。

Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson's disease.

机构信息

Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

Department of Pharmacy, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.

出版信息

Int J Pharm. 2020 Mar 15;577:119053. doi: 10.1016/j.ijpharm.2020.119053. Epub 2020 Jan 22.

DOI:10.1016/j.ijpharm.2020.119053
PMID:31981707
Abstract

As a major cause of neurodegeneration in the elderly, Parkinson's disease (PD) has attracted intense research attention. PD results from a decline in the numbers of dopaminergic neurons. Due to low levels of plasma exposure and the drug efflux properties of neuronal cells, orally delivering anti-PD drugs is challenging. Nanocrystals (NCs) can increase dissolution velocities and saturation solubility, improving oral bioavailability and brain uptake. In this study, Ginkgolide B (GB), a potent anti-Parkinsonism compound, was selected to verify the utility of NCs to effectively accumulate GB in both the blood and brain. Highly stabilized GB-NCs had small sizes, high rates of dissolution, enhanced cellular uptake and permeability. The GB-NCs could protect neurons against cytotoxicity induced by MPP, and showed no toxicity in zebrafish. Fluorescent imaging in zebrafish indicated high levels of the NCs in both the gut and brain. When orally administrated to rats, the GB-NCs showed higher drug plasma levels and neuronal drug distributions when compared to control groups. Importantly, in MPTP-induced PD model, GB-NCs treatment resulted in improved behavior, reduced dopamine deficiency, and elevated dopamine metabolite levels. In summary, these highlight the fabrication of GB-NCs as effective drug carriers for the neuronal delivery of anti-PD therapies.

摘要

作为老年人神经退行性疾病的主要病因,帕金森病(PD)引起了人们的强烈关注。PD 是由于多巴胺能神经元数量减少引起的。由于血浆暴露水平低和神经元细胞的药物外排特性,口服给予抗 PD 药物具有挑战性。纳米晶体(NCs)可以提高溶解速度和饱和溶解度,从而提高口服生物利用度和脑内摄取。在这项研究中,选择银杏内酯 B(GB)作为一种有效的抗帕金森病化合物,以验证 NCs 有效积聚 GB 于血液和脑中的效用。高度稳定的 GB-NCs 具有较小的尺寸、较高的溶解速率、增强的细胞摄取和通透性。GB-NCs 可以保护神经元免受 MPP 诱导的细胞毒性,并且在斑马鱼中没有毒性。斑马鱼的荧光成像表明 NCs 在肠道和大脑中均有高水平积聚。当以口服方式给予大鼠时,与对照组相比,GB-NCs 组的药物血浆水平和神经元药物分布更高。重要的是,在 MPTP 诱导的 PD 模型中,GB-NCs 治疗可改善行为,减少多巴胺缺乏,并提高多巴胺代谢物水平。总之,这些研究突出了 GB-NCs 的制备作为神经元传递抗 PD 治疗的有效药物载体。

相似文献

1
Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson's disease.高稳定性纳米晶体递送白果内酯 B 以预防帕金森病。
Int J Pharm. 2020 Mar 15;577:119053. doi: 10.1016/j.ijpharm.2020.119053. Epub 2020 Jan 22.
2
Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson's Disease.基于聚合物纳米粒子的脑内递药:改善银杏内酯 B 治疗帕金森病的疗效。
Int J Nanomedicine. 2020 Dec 24;15:10453-10467. doi: 10.2147/IJN.S272831. eCollection 2020.
3
Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy.葛根素纳米晶的口服给药以提高脑内蓄积和抗帕金森病功效。
Mol Pharm. 2019 Apr 1;16(4):1444-1455. doi: 10.1021/acs.molpharmaceut.8b01012. Epub 2019 Mar 6.
4
Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.大鼠模型静脉输注银杏二萜内酯后银杏内酯A、银杏内酯B和银杏内酯K的药代动力学及组织分布
J Pharm Biomed Anal. 2016 Jul 15;126:109-16. doi: 10.1016/j.jpba.2016.04.035. Epub 2016 Apr 25.
5
Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.食物和性别对大鼠口服银杏萜内酯提取物后银杏内酯A、B、C及白果内酯药代动力学的影响。
J Pharm Biomed Anal. 2014 Nov;100:138-144. doi: 10.1016/j.jpba.2014.07.030. Epub 2014 Aug 2.
6
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.载双药脂质纳米粒透过血脑屏障在鱼藤酮诱导的帕金森病小鼠模型中赋予增强的神经保护作用。
ACS Chem Neurosci. 2016 Dec 21;7(12):1658-1670. doi: 10.1021/acschemneuro.6b00207. Epub 2016 Oct 3.
7
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation.通过纳米晶体制剂提高白藜芦醇的口服生物利用度和抗帕金森病疗效。
Asian J Pharm Sci. 2020 Jul;15(4):518-528. doi: 10.1016/j.ajps.2019.04.003. Epub 2019 May 24.
8
A novel oil-body nanoemulsion formulation of ginkgolide B: pharmacokinetics study and in vivo pharmacodynamics evaluations.银杏内酯B的新型油体纳米乳剂配方:药代动力学研究及体内药效学评价
J Pharm Sci. 2014 Apr;103(4):1075-84. doi: 10.1002/jps.23866. Epub 2014 Feb 4.
9
Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs.三种不同银杏内酯B制剂经口给予比格犬后银杏内酯B的药代动力学
Molecules. 2015 Nov 6;20(11):20031-41. doi: 10.3390/molecules201119678.
10
Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson's Disease.银杏内酯 B 和原儿茶酸在治疗帕金森病方面的协同作用。
Molecules. 2020 Aug 31;25(17):3976. doi: 10.3390/molecules25173976.

引用本文的文献

1
Ginkgolide B attenuates hyperlipidemia by restoring sphingolipid homeostasis and activating PPARα and Nrf2 pathways.银杏内酯B通过恢复鞘脂稳态以及激活过氧化物酶体增殖物激活受体α(PPARα)和核因子E2相关因子2(Nrf2)信号通路来减轻高脂血症。
Sci Rep. 2025 Aug 6;15(1):28774. doi: 10.1038/s41598-025-14626-4.
2
Minocycline Nanocrystals: A New Approach for Treating Acne with Reduced Systemic Side Effects.米诺环素纳米晶体:一种治疗痤疮且全身副作用减少的新方法。
Pharmaceutics. 2025 May 31;17(6):727. doi: 10.3390/pharmaceutics17060727.
3
Ginkgolide B regulates apoptosis, oxidative stress, and mitochondrial dysfunction in MPP-induced SK-N-SH cells by targeting HDAC4/JNK pathway.
银杏内酯B通过靶向HDAC4/JNK通路调节MPP诱导的SK-N-SH细胞中的细胞凋亡、氧化应激和线粒体功能障碍。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 29. doi: 10.1007/s00210-025-03815-7.
4
Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier.改善帕金森病的治疗:利用光热和吞噬作用驱动左旋多巴纳米载体穿越血脑屏障的递送
Asian J Pharm Sci. 2024 Dec;19(6):100963. doi: 10.1016/j.ajps.2024.100963. Epub 2024 Aug 30.
5
Enhancing the Efficacy of Active Pharmaceutical Ingredients in Medicinal Plants through Nanoformulations: A Promising Field.通过纳米制剂提高药用植物中活性药物成分的功效:一个前景广阔的领域。
Nanomaterials (Basel). 2024 Oct 3;14(19):1598. doi: 10.3390/nano14191598.
6
Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics.口服吸收中的药物纳米晶体:影响药代动力学的因素
Pharmaceutics. 2024 Aug 29;16(9):1141. doi: 10.3390/pharmaceutics16091141.
7
[Not Available].[无可用内容]
Acta Pharm Sin B. 2024 Jan;14(1):1-19. doi: 10.1016/j.apsb.2023.09.014. Epub 2023 Sep 23.
8
Design and Evaluation of Ginkgolides Gastric Floating Controlled Release Tablets Based on Solid Supersaturated Self-nanoemulsifying.基于固体超饱和自微乳释药系统的银杏内酯胃漂浮型控释片的设计与评价。
AAPS PharmSciTech. 2023 Dec 26;25(1):7. doi: 10.1208/s12249-023-02717-2.
9
Nanophytomedicines as Therapeutic Agents for Parkinson's Disease.纳米植物药作为帕金森病的治疗药物
ACS Omega. 2023 Nov 2;8(45):42045-42061. doi: 10.1021/acsomega.3c04862. eCollection 2023 Nov 14.
10
Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy.草药纳米晶体:一种有潜力的新型治疗策略。
Molecules. 2023 Aug 31;28(17):6370. doi: 10.3390/molecules28176370.